Discover Dotmatics: San Francisco
Discover Dotmatics: San Francisco is an exclusive networking event on May 29, 2025, at Chandlery at the Shore featuring live demos and discussions led by Dotmatics leaders Phil Mounteney, Andrew LeBeau, and Maria Basanta on innovations in scientific workflows, including Dotmatics Luma, ELN updates, and Protein Metrics advancements.
Join us on Thursday, May 29th to Discover Dotmatics. Network and discuss business challenges as you hear from Dotmatics’ Phil Mounteney, Andrew LeBeau, and Maria Basanta on breaking innovation barriers at the intersection of science and technology.
Your Exclusive Invitation
Enjoy dining, libations, and the beautiful view at Chandlery at the Shore. Our Discover Dotmatics events are designed for industry experts to learn about advancements designed to accelerate discovery and streamline scientific workflows. During Discover Dotmatics: San Francisco, you will get the chance to experience live demos of Dotmatics Luma, hear about upcoming ELN release updates, and Protein Metrics advancements.
Register today as spots are limited.
Featured Speakers
- Maria Basanta, PhD, Director of NA Sales and Strategic Accounts
- Phil Mounteney, Vice President of Science and Technology
- Andrew LeBeau, Vice President, Product Management
Event Details
- Date: May 29, 2025
- Time: 5:30 - 8 PM
- Location: Chandlery at the Shore
Related
Limitations of Existing Life Science Software—and the Opportunity to Evolve
Existing life science software tools like ELNs, LIMS, and SDMS, while essential for digitizing workflows and managing data, are limited by their siloed, non-real-time, and non-AI-integrated designs, presenting an opportunity to evolve by integrating them into unified, intelligent platforms—such as Dotmatics Luma—that enable connected, workflow-aware, multimodal scientific intelligence with adaptive workflows, real-time data flow, and cross-functional insights without replacing core systems.
Dotmatics Hosts Successful 2021 User Symposium
Dotmatics' 2021 virtual User Symposium featured leadership updates with Mike McKee as new CEO, customer presentations from major companies like Novo Nordisk emphasizing the need for updated, user-driven ELN systems with federated search capabilities, and provided attendees with insights and resources to enhance R&D through the Dotmatics platform.
The Rise of Biotech: Why Smaller Companies Are Outpacing Big Pharma on Innovation
Smaller biotech companies are increasingly outpacing big pharmaceutical firms in new molecular entity approvals due to their greater agility, willingness to take risks, and freedom to innovate despite funding challenges, with over half of upcoming blockbuster drug launches expected from first-time launchers who face higher risks but also potential for significant success.
From Data Silos to AI-Ready Science: The Vision Behind Dotmatics Luma
Dotmatics Luma is a new, AI-driven, multimodal scientific platform designed to overcome data silos and fragmented R&D systems by uniting diverse scientific software and streamlining workflows across biologics, small molecule, and materials discovery, enabling smarter, faster, and more collaborative drug discovery and therapeutics development at the enterprise level.
Addressing Inefficient R&D Workflows
The blog discusses how legacy, fragmented R&D systems hinder innovation in complex, multi-domain scientific research by creating silos and inefficiencies, and presents Dotmatics’ unifying platform as a comprehensive solution that integrates diverse tools, data, and teams to enable smarter collaboration, governed data use, and AI-driven automation for faster, more rigorous innovation.
Dotmatics Names Michael Swartz as Chief Strategy Officer
Dotmatics has appointed Michael Swartz, a pioneer in digital transformation of life sciences R&D labs and former Senior VP of Enterprise Product Strategy involved in developing the Dotmatics Luma® Scientific Intelligence Platform, as Chief Strategy Officer to lead long-term strategic initiatives enhancing the company's AI-powered scientific software solutions that unify and analyze complex R&D data for improved decision-making.